Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
शेयरों में रैंक #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
शेयर मूल्य
$0.78611575
मार्केट कैप
$60.45M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-12.06%
देश
NO
व्यापार Lytix Biopharma AS (LYTIX)

श्रेणी

Lytix Biopharma AS (LYTIX) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.83 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $1.84 (2021-06-01 को)
Lytix Biopharma AS के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$549.38 38.22%
US
$1.05K 58.78%
NL
$145.41 454.58%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH